CoreFirst Bank & Trust’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.5K | Buy |
+872
| New | +$33.5K | 0.02% | 237 |
|
|
2025
Q1 | – | Sell |
-1,752
| Closed | -$59.3K | – | 202 |
|
|
2024
Q4 | $59.3K | Hold |
1,752
| – | – | 0.04% | 203 |
|
|
2024
Q3 | $71.6K | Buy |
+1,752
| New | +$71.6K | 0.04% | 190 |
|
|
2024
Q2 | – | Sell |
-1,752
| Closed | -$75.1K | – | 214 |
|
|
2024
Q1 | $75.1K | Sell |
1,752
-160
| -8% | -$6.86K | 0.05% | 189 |
|
|
2023
Q4 | $70.9K | Hold |
1,912
| – | – | 0.05% | 195 |
|
|
2023
Q3 | $69.3K | Hold |
1,912
| – | – | 0.05% | 204 |
|
|
2023
Q2 | $68.1K | Sell |
1,912
-224
| -10% | -$7.98K | 0.05% | 200 |
|
|
2023
Q1 | $76K | Sell |
2,136
-920
| -30% | -$32.7K | 0.06% | 186 |
|
|
2022
Q4 | $107K | Buy |
+3,056
| New | +$107K | 0.08% | 177 |
|
|
2022
Q3 | – | Sell |
-4,657
| Closed | -$253K | – | 397 |
|
|
2022
Q2 | $253K | Hold |
4,657
| – | – | 0.2% | 110 |
|
|
2022
Q1 | $254K | Hold |
4,657
| – | – | 0.17% | 116 |
|
|
2021
Q4 | $257K | Hold |
4,657
| – | – | 0.17% | 118 |
|
|
2021
Q3 | $222K | Hold |
4,657
| – | – | 0.15% | 126 |
|
|
2021
Q2 | $232K | Hold |
4,657
| – | – | 0.16% | 126 |
|
|
2021
Q1 | $208K | Hold |
4,657
| – | – | 0.14% | 131 |
|
|
2020
Q4 | $214K | Buy |
+4,657
| New | +$214K | 0.16% | 120 |
|